第一作者机构:[1]Fudan Univ, Liver Canc Inst, Shanghai, Peoples R China[2]Fudan Univ, Zhongshan Hosp, Shanghai, Peoples R China[3]Fudan Univ, Liver Canc Inst, Dept Liver Surg & Transplantat, Shanghai, Peoples R China[4]Sun Yat Sen Univ, Canc Ctr, Dept Liver Surg, Guangzhou, Peoples R China[5]Univ Sci & Technol China, Affiliated Hosp 1, Hefei, Peoples R China[6]Huazhong Univ Sci & Technol, Tongji Hosp, Dept Hepatobiliary Surg, Wuhan, Peoples R China[7]Sichuan Univ, West China Hosp, Dept Liver Surg, Sichuan, Peoples R China[8]Sichuan Univ, West China Hosp, Liver Transplantat Ctr, Sichuan, Peoples R China[9]Shanghai Canc Ctr, Liver Surg Dept, Shanghai, Peoples R China[10]Naval Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Hepat Surg II, Shanghai, Peoples R China[11]Sun Yat Sen Univ, Canc Ctr, Guangzhou, Peoples R China[12]Shanghai Tenth Peoples Hosp, Shanghai, Peoples R China[13]Peking Univ Peoples Hosp, Dept Hepatobillary Surg, Beijing, Peoples R China[14]Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Canc Ctr, Natl Clin Res Ctr Canc,Dept Hepatobiliary Surg, Beijing, Peoples R China[15]Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Guangzhou, Peoples R China[16]Xi An Jiao Tong Univ, Affiliated Hosp 1, Xian, Peoples R China[17]Peoples Liberat Army Gen Hosp, Med Ctr 5, Beijing, Peoples R China[18]Univ Elect Sci & Technol China, Sichuan Canc Hosp & Inst, Sichuan Canc Ctr, Sch Med, Chengdu, Peoples R China
推荐引用方式(GB/T 7714):
Sun Hui-Chuan,Fan Jia,Zhou Jian,et al.Clinical practice status of the adjuvant therapy in hepatocellular carcinoma (HCC): A survey of Chinese hepatobiliary surgeons[J].JOURNAL OF CLINICAL ONCOLOGY.2022,40(16):E16127-E16127.
APA:
Sun, Hui-Chuan,Fan, Jia,Zhou, Jian,Chen, Minshan,Liu, Lianxin...&Wang, Haiqing.(2022).Clinical practice status of the adjuvant therapy in hepatocellular carcinoma (HCC): A survey of Chinese hepatobiliary surgeons.JOURNAL OF CLINICAL ONCOLOGY,40,(16)
MLA:
Sun, Hui-Chuan,et al."Clinical practice status of the adjuvant therapy in hepatocellular carcinoma (HCC): A survey of Chinese hepatobiliary surgeons".JOURNAL OF CLINICAL ONCOLOGY 40..16(2022):E16127-E16127